Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International multicentre phase 3 study of intravenous human normal immunoglobulin (I10E) in CIDP
2013-005557-73Phase 3Completed
- Sponsor
- LFB Group
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of subcuvia in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by LFB Group. Primary endpoint: Responder rate at end of study (EOS) visit. Started Aug 2014; status: completed.
02
Drugs
subcuvia
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2013-005557-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005557-73.